UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 18, 2015 4:05 P.M.

Form:	S-3
CIK: 0001006281 Company Name: Protalix BioTherapeutics, Inc. File Number: 333-208004